Moexipril-d5 Catalog No.:M26575-C GSK-1292263

GSK-1292263

a PHGDH inhibitor

Smiles: CS(=O)(=O)CCCN1C(CN2C3C=NC=CC=3N(CC(F)(F)F)C2=O)=CC2C=C(Cl)C=CC1=2

and increases FITC-dextran permeability in Schlemm’s canal endothelial (SCE) cell monolayers

4-dioxo-1-phenylheptan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]hydrazinyl]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(1S

Moexipril-d5 Catalog No.:M26575-C GSK-1292263Moexipril d5 is the deuterium labeled Moexipril. Moexipril hydrochloride is a potent orally active non sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. Product information CAS Number: 1356929 49 1 Molecular Weight: 503. 60 Formula: C27H34N2O7 Chemical Name: (3S) 2 [(2S) 2 {[(2S) 1 ethoxy 1 oxo 4 [(2,3,4,5,6 H)phenyl]butan 2 yl]amino}propanoyl] 6,7 dimethoxy 1,2,3,4